Analyst firms · Morgan Stanley · TMCI

Morgan Stanley TMCI price target and rating history

Treace Medical Concepts Inc. (TMCI) · Health Care

Morgan Stanley rates Treace Medical Concepts Inc. (TMCI) Equal-Weight with a $5.50 price target, as of its latest action on May 8, 2024. It has published 3 rating actions on TMCI since January 2022, including 1 upgrade and 1 downgrade.

Current rating
Equal-Weight
Price target
$5.50
Median target, all firms
Too few
Actions on TMCI
3

Morgan Stanley price target on TMCI

$30$18$5.502023202420252026
Morgan Stanley price target on TMCI, each point a stated target, January 2022 to May 2024.

Every Morgan Stanley rating on TMCI

Questions about Morgan Stanley and TMCI

What is Morgan Stanley's price target for TMCI?
Morgan Stanley's latest stated price target for Treace Medical Concepts Inc. (TMCI) is $5.50, from its action on May 8, 2024.
What is Morgan Stanley's rating on TMCI?
Morgan Stanley rates TMCI Equal-Weight, a neutral rating, as of May 8, 2024.
When did Morgan Stanley last change its view on TMCI?
On May 8, 2024, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $15 to $5.50.

More TMCI rating histories

All Morgan Stanley ratingsTMCI news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.